Amazon could be the largest retailer in 2024, according to a report while FTX is suing former disgraced CEO Sam Bankman-Fried to retrieve funds. And the Directors Guild of America members voted in favor of a new contract.
Share:
More In Business
This Week's Top Stories: First Republic Woes, Exxon Mobil Surge & Amazon Dips
The Week's Top Stories is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
Cheddar Afternoon News Briefings of April 28th
Cheddar Afternoon News Briefings
Afternoon Alexa Flash Briefings of April 28th
Afternoon Alexa Flash Briefings
Stock Market Today: Wall Street Rises to Cap a Winning April
Wall Street closed out a winning April with gains Friday after more companies said their profits at the start of the year weren’t as bad as expected.
Fed's Powell Was Tricked by Fake Call From Russia Pranksters
Federal Reserve Chair Jerome Powell was tricked into an extended phone call in January with Russian pranksters posing as Ukrainian President Volodymyr Zelenskyy, during which Powell appeared to discuss the economic impact of interest rate hikes.
Amazon Q1 Revenue, Profit Grow but Cloud Unit a Concern
Amazon on Thursday reported stronger-than-expected revenue and profits for the first quarter, sending its stocks higher in after-hours trading. But its prices took a dip in the evening amid concerns about a continued slowdown in the company's profitable cloud computing unit AWS.
Morning Alexa Flash Briefings of April 28th
Morning Alexa Flash Briefings
Key Inflation Gauge Tracked by the Fed Remained High in March
A key index of underlying inflation that is closely followed by the Federal Reserve remained elevated last month, keeping the Fed on track to raise interest rates next week for the 10th time since March of last year.
Powerful New Obesity Drug Poised to Upend Weight Loss Care
As a growing number of overweight Americans clamor for Ozempic and Wegovy — drugs touted by celebrities and on TikTok to pare pounds — an even more powerful obesity medicine is poised to upend treatment.
